Poorly controlled, obese, Type II diabetics were studied before, during, and 3 months after a weight reduction program that used supplemented fasting (200 kcal or 0.9 MJ/day). During fasting, the very low density lipoprotein (VLDL) triglycerides (TG) decreased, as did the adipose tissue lipoprotein lipase (AT-LPLA) and skeletal muscle lipoprotein lipase (SM-LPLA) activities. Three months later VLDL TG remained low (-59%), while high density lipoprotein cholesterol was higher ( + 11%) and blood glucose control improved compared with values on admission. The fractional removal rate (K 2 ) at the i.v. fat tolerance test (IVFTT) and the SM-LPLA were unchanged, while AT-LPLA (expressed per gram of wet weight, but not as whole-body AT-LPLA) increased by 25%. There were no significant correlations between AT-LPLA and the lipoprotein TG concentrations or K 2 -IVFTT, although there were significant positive correlations between SM-LPLA and K 2 -IVFTT, both on admission and after body weight stabilization. This may indicate that SM-LPLA is more directly related to the capacity to remove lipoprotein TG, at least in obese diabetic patients. K 2 -IVFTT was inversely correlated to the VLDL TG and cholesterol concentrations both before and 3 months after fasting. Because both SM-LPLA and K 2 -IVFTT were unchanged after body weight reduction, the change in VLDL TG may be mainly due to a reduced rate of lipoprotein synthesis. (Arteriosclerosis 5:93-100, January/February 1985)
T ype II diabetes is associated with an increased risk for ischemic heart disease. 1 The reason for the high incidence of atherosclerotic cardiovascular disease is not known. However, a deranged lipoprotein metabolism, characterized by increased very low density lipoprotein (VLDL) lipid concentrations and low high density lipoprotein (HDL) cholesterol (Choi) concentrations, may be a contributing factor. 23 Increased VLDL may be due to increased production or to impaired catabolism. The increased VLDL levels commonly seen in Type II diabetes are probably mainly due to overproduction, 4 -6 but the activity of lipoprotein lipase, the key enzyme in the breakdown of triglyceride (TG)-rich lipoproteins in mean age of 56 years (range, 36-63 years) were studied. They were referred to the Department of Geriatrics because they had poorly controlled Type II diabetes despite dietary treatment for at least 6 months before admission. Twelve of the patients were also being treated with sulfonylurea derivatives; in one case it was combined with metformin. All patients had a relative body weight above 1.19, according to Broca's index. The mean value for men was 1.37 (range 1.19-1.75) and for women, 1.52 (1.20-1.93) . No patient had significantly impaired renal function, but several suffered from atherosclerotic cardiovascular disease. None, however, had experienced a major heart attack in the 3 months before admission. The clinical characteristics of the patients have been given earlier. 16 All patients gave informed consent in accordance with institutional guidelines.
Design of the Study
The first 2 days after admission, the patients were given an ordinary isocaloric diabetic diet. This was followed by 3 days of successively decreasing calorie intake. The fasting period lasted for 3 weeks. All antidiabetic drugs were removed during fasting. During this period of supplemented fasting, the patients consumed mainly juices from fruits and berries and vegetable beverages and had free access to water and unsweetened tea and coffee. To assure a minor intake of protein and carbohydrates and an adequate intake of vitamins and minerals, these drinks were supplemented with 30 g of a nutrition formula preparation (Meritene from Wander AG, Bern, Switzerland). The approximate calorie intake was 200 kcal/ day (0.9 MJ) with 13 g protein (26% of calories), 35 g carbohydrates (72%), and 1 g (4%) fat.
After 3 weeks of this diet, the calorie intake was gradually increased until the patients were eating an ordinary diabetic diet. Before discharge, the patients were given detailed dietary advice by experienced dietitians and were told to eat a calorie-restricted, conventional diabetic diet for a further slow reduction of body weight.
Many patients received fewer antidiabetic drugs during the 3-month follow-up period than before admission. 18 Three patients, who had earlier been treated with sulfonylurea, were now treated only by diet, and several others reduced their intake of drugs. Only one patient, who before weight reduction had diabetes that was very poorly controlled by diet only, received an additional 2.5 mg of glibenclamide after the fasting period.
Patients were investigated at a visit to the outpatient clinic 3 months after discharge. All but three of the patients were reexamined at this time. Another two subjects completed the trial schedule but were excluded later because of lack of data at the followup examination. However, the body weight and blood glucose changes in these two patients were similar to those of the others. One patient did not return for the final outpatient examination.
Blood Sampling
Blood was drawn for analysis during the first 2 days after hospital admission when the patients were on a conventional isocaloric diabetic diet, during the last 2 days of the fasting period, and finally 3 months after discharge when the patients were on an ordinary diabetic diet. All tests were performed after an overnight fast.
The blood glucose and urinary glucose concentrations were determined by the glucose oxidase method. 17 The serum insulin concentrations were measured with the Phadebas (Pharmacia, Uppsala, Sweden) test method based on a radioimmunological technique. 18 The TG and cholesterol (Choi) concentrations in serum and in the isolated lipoprotein fractions were determined by semiautomated methods in a Technicon Autoanalyzer II 19 by using a combination of preparative ultracentrifugation 20 and heparin-manganese precipitation 21 to separate VLDL, the low density lipoproteins (LDL), and HDL as earlier described. 22 The apolipoprotein (apo) A-l, A-ll, and B concentrations in serum were determined by electroimmunoassay. 22 Specimens of abdominal adipose tissue and of skeletal muscle from the lateral vastus muscle were taken for determination of LPLA as described earlier, 23 with slight modifications. 24 Thus, a triolein-phospholipid emulsion 25 and a heparin concentration of 2 g/liter (about 240 ILJ/ml) were used for both adipose and skeletal muscle tissue. The activity was expressed in mU/g (1 mU = 1 nmol fatty acid released per minute). The intravenous fat tolerance test was performed as described by Carlson and Rossner. 26 
Statistics
Means and standard errors were calculated by ordinary methods. Tests of the hypothesis of equal means and contrasts in the means for the different periods were, for each variable, tested in a three-way analysis of variance (ANOVA) model. Relationships between dependent variables and explanatory variables were also estimated by a stepwise regression technique.
Results

Metabolic Effects of Fasting and Feeding
During fasting, there was a significant decrease in blood glucose levels, fasting serum insulin concentrations, and body weight ( Table 1 ). During the same period, TG levels in both VLDL and HDL ( Figure 1 ) decreased significantly in spite of a concomitant decrease in both the skeletal muscle lipoprotein lipase activity (SM-LPLA) and the adipose tissue lipoprotein lipase activity (AT-LPLA) ( Table 1 ). The fractional removal rate (Kj) at the IVFTT remained unchanged at the end of the fasting period. The HDL Choi and the serum apo A-l, A-ll, and B concentrations decreased significantly. Three months after discharge from the hospital, body weight was stabilized at a mean level of 7 kg below original body weight. The mean body weight change during the preceding month was 0.4 kg (range from -2 . 3 to +2.0 kg). The VLDL TG remained significantly lower than on admission ( Figure  1 ). The HDL Choi had increased to a level significantly higher than on admission, while apo A-l, A-ll, and B had reverted to pretreatment levels. The TG removal capacity, measured as K^IVFTT, was similar to that before fasting, as was also SM-LPLA. However, the AT-LPLA measured per gram of wet weight had increased to a mean level significantly higher than on admission (Table 1) .
Table 1. Effects of Supplemented Fasting on Overweight Type II Diabetics
When tested by stepwise regression analysis, neither AT-LPLA nor SM-LPLA was significantly dependent on body weight, fasting blood glucose, or fasting serum insulin concentrations either on admission, during the last days of the fasting period, or at 3 months after the end of fasting.
Relationships between Llpoproteln-Llpld Concentrations and Trlglycerlde-Removal Capacity before Treatment
On admission, there were significant negative correlations between rCrlVFTT and TG concentrations in VLDL, HDL, and serum (Table 2 ). Furthermore, there was a significant correlation between r^-IVFTT and SM-LPLA (Table 2, Figure 2 A) due to high hC, in patients with high SM-LPLA. This correlation (r = 0.82, p < 0.0003) dropped to r = 0.53, p = 0.06 when the outlier was excluded. No similar relationship existed between rCj-IVFTT and AT-LPLA ( Figure 2 B ). Nor were there any significant relationships between AT-LPLA and lipoprotein lipid and apolipo- On admission, there were no significant independent correlations between lipoprotein lipid and apolipoprotein concentrations on the one hand, and body weight, fasting blood glucose, or fasting serum insulin concentrations on the other.
Changes of Lipoprotein Composition and Triglycerlde-Removal Capacity during Fasting
After 3 weeks of fasting, there remained no significant correlations between fasting lipid and apolipoprotein concentrations on the one hand and AT-LPLA, SM-LPLA, and rC,-IVFTT on the other (Table  2 ). At this time there were, however, positive independent correlations between the fasting serum insulin concentrations and the VLDL TG, apo A-l, and apo A-ll concentrations, respectively (Table 2) . Also, there were significant negative correlations between LDL Choi and serum Choi, respectively, and body weight.
The reduction of the TG concentrations in VLDL, HDL, and serum during fasting was most pronounced in subjects with high pretreatment values and was positively correlated to the K 2 -IVFTT before treatment ( Table 3 ). The greatest TG reductions were seen in patients with low K 2 -IVFTT and high initial TG concentrations. The reductions of VLDL TG and serum TG were directly related to the changes in body weight during fasting.
Although the mean value of LDL Choi did not change, the individual changes during fasting were significantly negatively correlated with the pretreatment SM-LPLA (p < 0.01). Thus, patients showing increasing LDL Choi concentrations during fasting apparently had low SM-LPLA on admission, while reductions took place in those with lower TG, higher LDL Choi, and more efficient TG removal capacity. Compatible with this, there was a positive relationship between the individual changes of LDL Choi and those of SM-LPLA during fasting (p < 0.05).
There were no strong significant correlations between AT-LPLA and other parameters tested. A weak positive correlation was seen between the change of AT-LPLA during fasting and the change of VLDL Choi (Table 3) .
Relationships between Llpoproteln Composition and Trlglycerlde-Removal Capacity at 3-Month Follow-Up
At the examination 3 months after discharge when body weight was stabilized, there were still negative correlations between the VLDL-lipid concentrations and rCj-IVFTT (Table 2 ). There was also a positive correlation between r^-IVFTT and SM-LPLA. This relationship depended totally on one subject with high SM-LPLA and high rylVFTT, but the slope and correlation value with this extreme value included were similar to those observed at admission. AT-LPLA did not correlate to the lipoprotein lipid concentrations or to K 2 -IVFTT, but there was a significant independent correlation between AT-LPLA and apo A-I (Figure 3) .
Of the lipoprotein lipid concentrations, only the VLDL lipids remained significantly lower than on admission ( Figure 1 ). The change of VLDL TG during the whole 4-month period was correlated to the initial capacity to remove TG-rich lipoproteins as measured by rC,-IVFTT (Table 4 ). Decreasing VLDL levels were seen mainly in patients with initially low LDL Choi and low TG-removal capacity who also tended to have increased HDL Choi during treatment.
Concentrations of LDL TG, HDL TG, serum TG, serum Choi, and serum apo B were significantly correlated to the fasting blood glucose concentrations ( Table 2 ). The changes in serum TG up to 3 months after fasting were significantly correlated to the changes in fasting blood glucose (Table 4 ). This indicated that the degree of glucose control was a major influence on lipoprotein composition at this time.
The HDL Choi concentrations had increased significantly (11%) after 4 months. The changes in HDL Choi were correlated to pretreatment body weight and fasting serum insulin concentrations, and the most pronounced increase was seen in patients with high body weight and high fasting serum insulin concentrations before weight reduction. However, the HDL Choi changes did not correlate significantly to changes of either AT-LPLA, SM-LPLA, r^-IVFTT, body weight, fasting-blood glucose, or serum insulin concentrations.
On this occasion, AT-LPLA was significantly higher (Table 1 ) than on admission. However, the changes of AT-LPLA were not significantly correlated to lipoprotein TG changes or to Kj-IVFTT or SM-LPLA.
Discussion
The reduction of VLDL lipid levels during fasting is probably mainly due to reduced lipoprotein synthesis. This thesis is supported by our demonstration of decreasing LPLA in skeletal muscle and adipose tissues and unchanged r^-IVFTT. Streja et al. 27 have reported a reduction in TG production and removal during prolonged fasting in obese subjects. Taskinen et al. 28 reported reductions of the heparin-releasable LPLA in adipose tissue and skeletal muscle during a restricted caloric intake in healthy volunteers. They estimated that the relative contribution of skeletal muscle lipase to total LPLA increased upon starvation. This was not apparent in our present study, if we consider that the total adipose tissue mass 29 was reduced by approximately 20% to 25% during fasting. Calculated as total body LPLA, we estimate that both SM-LPLA and AT-LPLA decreased about 50% during fasting. The reduction of AT-LPLA in this study was less pronounced than that reported by Taskinen et al. 28 but similar to that reported by others, who observed a 50% reduction. 7123031 Others reported 32 ' & an unchanged or slightly increased rC,-IVFTT in obese subjects during fasting.
The VLDL reduction that persisted after 4 months also seems to be due to reduced lipoprotein synthesis, because the Kj-IVFTT remained unchanged. Higher AT-LPLA measured per gram of wet weight was not significantly correlated to the VLDL lipid levels, nor were the changes of AT-LPLA significantly correlated to the changes of the VLDL lipid levels. We estimate that the mean reduction of body weight by 7 kg should be comparable to a 15% to 20% loss of total body fat. 28 Thus, measured as whole-body AT-LPLA, the activity of adipose tissue LPL did not undergo any major change at the follow-up examination. Schwartz and Brunzell 34 found a raised AT-LPLA with increased activity after body-weight reduction in moderately obese nondiabetic men, while S6rbris et al. 33 reported an unchanged LPLA after weight reduction. However in the former study, the increase in AT-LPLA occurred after a more pronounced weight loss than that achieved by our patients.
The mean AT-LPLA and SM-LPLA found in this study were similar to those found in healthy, nondiabetic subjects. 12 -313S As we had no healthy controls matched for sex and body weight, we cannot be sure that a subsample had decreased adipose tissue LPLA, as reported in obese patients with untreated Type II diabetes. 10 ' 12 In the present study, most of the patients were being treated with oral antidiabetic agents. However, it is remarkable that there were no significant correlations between the concentrations of TG or changes of TG concentrations in VLDL or serum and AT-LPLA at any time point. Neither were there any correlations between AT-LPLA and the TG-removal capacity measured as Kj-IVFTT (Figure  2 B ). On the other hand, there were positive correlations between SM-LPLA and rCrlVFTT, both on admission (Figure 2 A) and at follow-up after body weight stabilization. This suggests that SM-LPLA may be more directly correlated with the capacity to remove TG-rich lipoproteins than AT-LPLA, at least in obese, diabetic patients. One can speculate that the reduced insulin sensitivity of the tissues may also influence the effects of insulin on AT-LPLA.
A positive relationship between the fractional catabolic rate of VLDL apo B and AT-LPLA has been reported 38 in nonfasting, nondiabetic subjects, where one might expect stronger correlations with AT-LPLA than in fasting subjects. 37 The increase of HDL Choi concentrations 3 months after discharge should be beneficial with regard to coronary heart disease risk. 38 Reduced levels of HDL Choi during fasting 39^10 and increased HDL Choi levels when body weight is stabilized after weight reduction 333940 have been reported in obese subjects. Neither the levels of HDL Choi nor the changes in HDL Choi were significantly correlated to the TG-removal variables. Thus, there was no significant correlation between AT-LPLA and HDL Choi suggested for obese 28 ' ^4 1 and diabetic 10 ' 41 patients. Nor were there any significant correlations between Kj-IVFTT and HDL Choi as described in other studies. 42 There were, however, negative correlations between the changes of HDL Choi and VLDL TG and serum TG during the study period. This is compatible with the view that the HDL Choi increase may be due to the redistribution of surface material to HDL from the earlier increased VLDL pool when VLDL levels were decreased because of a reduced VLDL production after body weight reduction.
A positive relationship between AT-LPLA and the major peptide of HDL, apo A-l ( Figure 3 ), may be interpreted as indicating a specific role for AT-LPLA in the regulation of HDL metabolism. If the major contribution of apo A peptides to HDL is due to transfer of the A peptides from chylomicrons, 43 mediated by hydrolysis of the TG derived from exogenous fatty acids, it can be postulated that adipose tissue lipoprotein lipase plays a more important role in this transfer than skeletal muscle lipase, because AT-LPLA is the dominating lipase activity postprandially. 37 Magill et al. 36 reported that the fractional catabolic rate of apo A-l was inversely related to AT-LPLA, thus offering another explanation for the relationship between AT-LPLA and the serum concentration of apo A-l.
There was a significant negative correlation between the VLDL TG concentration and Kj-IVFTT both before fasting and at the 3-month follow-up. Although the mean value of SM-LPLA was not clearly decreased, it is obvious that patients with increased VLDL lipid levels had low K^-IVFTT and that low Kj-IVFTT tended to be accompanied by low SM-LPLA. There was no significant correlation to AT-LPLA. As discussed above, decreased TG concentration during fasting seems to be due to a decreased synthesis and not to an improved catabolic capacity, there was a significant relationship between Kj-IVFTT and SM-LPLA, on the one hand, and LDL Choi on the other before treatment. This means that the lowest LDL Choi values were seen in patients with a low K 2 -IVFTT and a low SM-LPLA. As discussed earlier, 44 this can be interpreted as due to a low conversion rate of VLDL particles to LDL as a result of the impaired capacity to degrade TG-rich lipoproteins.
